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An important property of micelles with particular significance in
pharmacy is their ability to increase the solubility of poorly soluble
drugs in water, thus increasing their bioavailability. In this work,
the solubilization of ibuprofen (IBU) was studied in micellar
solutions of three surfactants possessing the same hydrocarbon tail
but different hydrophilic head groups, namely sodium dodecyl
sulphate (SDS), dodecyltrimethylammonium bromide (DTAB), and
n-dodecyl octa(ethylene oxide) (C
12
EO
8
). The results showed that,
irrespective of the surfactant type, the solubility of IBU increased
linearly with increasing surfactant concentration, as a consequence
of the association between the drug and the micelles. The 80 mM
DTAB and the 80 mM C
12
EO
8
 micellar solutions resulted in a 16-
fold increase in solubility of IBU when compared to the buffer
solution, whereas the 80 mM SDS micellar solution resulted in a
5.5-fold increase in IBU solubility. The highest value of molar
solubilization capacity (χ) was obtained with DTAB, χ = 0.97,
followed by C
12
EO
8 
, χ = 0.72, and finally SDS, χ = 0.23. However,
due to the stronger tendency of the nonionic surfactant in forming
micelles in solution, at the same surfactant concentration, we
obtained the same solubility of IBU in both DTAB and C
12
EO
8
.
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INTRODUCTION
Surfactants are amphiphilic molecules, consisting of
both hydrophilic and hydrophobic regions. These
substances are known to play a vital role in many proces-
ses of interest in both fundamental and applied sciences.
One important property of surfactants is the formation of
colloidal-sized clusters in solutions, known as micelles,
which have particular significance in Pharmacy because
of their ability to increase the solubility of sparingly soluble
substances in water (Mall et al., 1996). The ambivalence
of amphiphiles towards an aqueous environment is
responsible for the phenomenon of self-association of in-
dividual surfactant molecules resulting in a variety of
micellar aggregate structures (Blankschtein et al., 1986).
The concentration of a monomeric amphiphile (surfactant
molecule) at which micelles appear is called the Critical
Micelle Concentration (CMC). The occurrence of a CMC
results from a delicate balance of intermolecular forces.
The main attractive force results from the hydrophobic
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interaction among the nonpolar surfactant tails, whereas
the main opposing repulsive force results from steric and
electrostatic interactions (in the case of ionic and
zwitterionic surfactants) between the surfactant polar head
groups (Israelachvili, 1985; Rangel-Yagui et. al., 2004).
Micelles are known to have an anisotropic water
distribution within their structure. In other words, the water
concentration decreases from the surface towards the core
of the micelle, with a completely hydrophobic (water-
excluded) core. These aggregates exhibit an interfacial
region separating the polar bulk aqueous phase from the
hydrocarbon-like interior (Tanford, 1980; Israelachvili,
1985). As a consequence, micellar solutions consist of a
special medium in which hydrophobic, amphiphilic or ionic
compounds may be solubilized and reagents may be
concentrated or separated in aqueous solution (Oliveira,
Chaimovich, 1993). Moreover, the spatial position of a
solubilized drug in a micelle will depend on its polarity:
nonpolar molecules will be solubilized in the micellar core
and substances with intermediate polarity will be
distributed along the surfactant molecules in certain
intermediate positions.
On the other hand, numerous drug delivery and drug
targeting systems have been studied in an attempt to
minimize drug degradation and loss, to prevent harmful side
effects, and to increase drug bioavailability (Gref et al.,
1994; Allen et al., 1995; Torchilin et al., 1995; Canto et al.,
1999; Jones & Leroux, 1999; Dalmora et al., 2001). Within
this context, the utilization of micelles as drug carriers
presents some advantages when compared to other
alternatives such as soluble polymers and liposomes.
Micellar systems can solubilize poorly soluble drugs and
thus increase their bioavailability, stay in the body (blood)
long enough to provide gradual accumulation in the
required area, and their sizes permit them to accumulate in
areas with leaky vasculature. Moreover, specific ligands
can be attached to their outer surface in order to optimize
the controlled release and specificity of pharmacological
effect. Another advantage is that the micelles can be
obtained in an easy and reproducible manner in large scale
(Torchilin, 2001).
Therefore, the utilization of aqueous micellar
solutions for drug solubilization can be advantageous for
drug delivery purposes, with the possibility of increasing
water solubility of poorly soluble drugs, improving
bioavailability, reducing toxicity and other side effects,
enhancing permeability across the physiological barriers,
and substantial change in drug distribution (Torchilin, 2001).
Usually, the solubilization of a molecule by a
surfactant can be evaluated based on two descriptors:
molar solubilization capacity, χ, and micelle-water partition
coefficient, K (Atwood, Florence, 1983). The c  value is
defined as the number of moles of the solute (drug) that
can be solubilized by one mol of micellar surfactant, and
characterizes the ability of the surfactant to solubilize the
drug. It can be calculated based on the general equation
for micellar solubilization:
(1)
where S
tot
 is the total drug solubility, S
W
 is the water drug
solubility, C
surf
 is the molar concentration of surfactant in
solution, and CMC is the critical micelle concentration
(Alvarez-Nuñes, Yalkowsky, 2000). Since above the CMC
the surfactant monomer concentration is approximately
equal to the CMC, the term (C
surf
 – CMC) is approximately
equal to the surfactant concentration in the micellar form
and, therefore, χ is equal to the ratio of drug concentration
in the micelles to the surfactant concentration in the
micellar form.
On the other hand, the micelle-water partition
coefficient is the ratio of drug concentration in the micelle
to the drug concentration in water for a particular
surfactant concentration, as follows:
 (2)
Combining Equations (1) and (2), we can relate the
two solubility descriptors. Accordingly, for a given
surfactant concentration:
 (3)
As can be seen, K
 
is related to the water solubility of
the compound, in contrary to χ  (Alvarez-Nuñes,
Yalkowsky, 2000). In order to eliminate the dependence of
K on the surfactant concentration, a molar micelle-water
partition coefficient, K
M
, can be defined as follows:
 (4)
Ibuprofen (4-isobutil-2-phenyl-propionic acid) (IBU),
pKa = 4.8 (Janjikhel, Adeyeye, 1999), is a well-known non-
steroidal anti-inflammatory drug widely used in
inflammatory therapy (Figure 1). The main disadvantages
of this family of drugs are the relatively short plasma half-
life, and the significant gut- and nephrite-toxicities (Simó
et al., 2002). Moreover, IBU is a poorly water-soluble drug
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(Janjikhel, Adeyeye, 1999). Therefore, the development of
a drug delivery system allowing the controlled release of
IBU would be useful, especially in high dose-dependent
treatments, including chronic diseases such as rheumatoid
arthritis.
Studies have been conducted on the transdermal
delivery of IBU aiming the decrease of the side effects
related to long-term treatments. Transdermal IBU delivery
systems based on polymers, nonionic polyethylene oxide
alkyl ether surfactants solutions, and liposomes have been
investigated (Liso et al., 1995; Bula, Ghaly, 1995; Park et
al., 2000; Suedee et al., 2002). The controlled release of
IBU from injectable poloxamer-based gels applied to
epidural analgesia was also studied by Paavola et al.
(1998), and it was shown that the poloxamer gel prolongs
the in vitro release of the drug relative to the corresponding
control formulations.
In this work, the influence of the hydrophilic portion
of surfactants (head group) on micellar solubilization of the
drug ibuprofen (IBU) was investigated. Three different
surfactants, a nonionic (n-dodecyl octa(ethylene oxide)),
a cationic (n- dodecyltrimethylammonium bromide), and an
anionic (sodium dodecyl sulphate), all presenting the same
tail length, were studied. Although the ionic surfactants
studied might be toxic and present restrictions for in vivo
use, their investigation contributes significantly to the
understanding of IBU solubilization.
MATERIAL AND METHODS
Material
Ibuprofen (IBU) and the cationic surfactant n-
dodecyltrimethylammonium bromide (DTAB) were from
Sigma (St. Louis, MO). The anionic surfactant sodium
dodecyl sulphate (SDS) was from Pharmacia Biotech
(Uppsala, Sweden). The nonionic surfactant n-dodecyl
octa(ethylene oxide) (C
12
EO
8
) was from Nikko Chemicals
(Tokyo, Japan). The solutions were prepared in 5 mM
phosphate buffer pH 7.4 (ionic strength = 0.011 M),
utilizing water purified through a Millipore Milli-Q ion-
exchange system (Bedford, MA). All the other reagents
were of analytical grade. The glassware used was washed
in a 50:50 ethanol:1 M sodium hydroxide bath, followed by
a 1 M nitric acid bath, rinsed copiously with Milli-Q water,
and finally dried in an oven.
Determination of ibuprofen concentrations
The concentration of IBU was determined
spectrophotometricaly at l
 
= 273 nm in a Beckman DU 640
(Fullerton, CA) spectrophotometer, utilizing a surfactant
solution at the same molar concentration as blank. The
extinction coefficient of the drug at this wavelenght was
found to be 256.5 M-1cm-1 (Ridell et al.., 1999).
Determination of critical micelle concentrations
(CMC)
The CMC  of the surfactants at 25 oC was
determined in pure water, phosphate buffer pH 7.4, as well
as in phosphate buffer in the presence of IBU at saturation
(4 mM). The CMC determinations for SDS and DTAB
were based on the change in conductance with surfactant
concentration, with the measurements performed in a
MPC 227 Mettler-Toledo (Columbus, OH) conductivi-
meter. The CMC determinations for C
12
EO
8
 were based
on the change in surface tension with surfactant concen-
tration. A DuNoüy ring tensiometer (model 21, Fischer
Scientific Tensiomat, Fair Lawn, NJ) was used to measure
the surface tension. Each conductivity/surface tension
measurement was repeated three times, and the typical
error in the CMC determination was less than 5%.
Solubility determination
The solubility of IBU in SDS, DTAB, and C
12
EO
8
solutions was measured at surfactant concentrations
between 0 and 85 mM. Excess amounts of IBU were
added to vials containing 2.0 mL of buffered surfactant
solutions (SDS, DTAB or C
12
EO
8
). The sample vials
were then rotated at 8 rpm in an end-to-end rotator
(Labquake, Barnstead/Thermolyne, Dubuque, IW) at
25 oC for 24 hours. After this period, the samples were
centrifuged at 8720 g for 20 minutes, 25 oC (Centrifuge
BR4, Jouan, Winchester, VA), and the concentration of
solubilized IBU determined spectrophotometrically as
described above. All the solubility experiments were
carried out in triplicate.
FIGURE 1 – Chemical structure of the anti-inflamatory
drug ibuprofen.
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Calculation of solubility descriptors
The values of χ and K
M
 were calculated from the
solubility curves obtained for IBU and the three surfactants
(S
tot
 vs. C
surf
) and Equations (1) and (4).
RESULTS AND DISCUSSION
Figure 2 and 3 show the conductance (κ) versus
surfactant concentration plots obtained for SDS and
DTAB, respectively, at 25 oC. The CMC is determined as
the intersection point between the two straight lines
obtained. Figure 4 shows the surface tension (γ) versus log
surfactant concentration plots for C
12
EO
8
, at 25 oC. Again,
the CMC is obtained from the intersection point between
the straight lines for low and high concentrations.
The results of CMC for the three surfactants studied
are summarized in Table I. The values obtained in water
are in agreement with previous values reported in
literature, according to which CMC
SDS
 = 8.2 mM,
CMC
DTAB
 = 16.0 mM (Rosen, 1989), and CMC
C12EO8
 =
88 µM (Preté et al., 2002). As can be seen, the CMC of
FIGURE 2 – Conductance (κ) as a function of sodium
dodecyl sulphate (SDS) concentration plots at 25 oC in A-
pure water, B-phosphate buffer pH 7.4, and C- ibuprofen-
saturated (4 mM) phosphate buffer pH 7.4.
FIGURE 3 – Conductance (κ) as a function of
dodecyltrimethylammonium bromide (DTAB) concentration
plots at 25 oC in A-pure water, B-phosphate buffer pH 7.4,
and C- ibuprofen-saturated (4 mM) phosphate buffer pH 7.4.
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ionic surfactants (SDS and DTAB) are considerably
higher than the CMC of the nonionic surfactant C
12
EO
8
,
as a consequence of the electrostatic repulsions among the
ionic surfactant head groups in the micelle. The low CMC
of nonionic surfactants, combined with the low toxicity,
makes this class of surfactants particularly interesting for
solubilization of drugs. The CMC of SDS and DTAB were
depressed in phosphate buffer. The depression of ionic
surfactants cmc in the presence of electrolytes is due
mainly to the decrease in the thickness of the electric
double layer surrounding the ionic head groups and
consequent decreased electrical repulsion between them
in the micelle (Florence,  Attwood, 2003). On the other
hand, the CMC of C
12
EO
8
 did not show significant change
in phosphate buffer, as expected. This nonionic surfactant
presents a polyethylene oxide (PEO) hydrophilic head
group that interacts with water through hydrogen bonds.
Therefore, the CMC should not change in the presence of
low concentration of electrolyte.
In the presence of IBU-saturated buffer, the CMC of
DTAB and C
12
EO
8
 were lowered, whereas no change was
observed for the CMC of SDS. In this respect, it has been
described that molecules solubilized in the outer portion of
the micelle core are most effective in reducing the CMC
than the ones solubilized in the inner core (Rosen, 1989).
Therefore, if solubilization of IBU took place, the drug should
be located in the inner core of SDS micelles, as a result of
hydrophobic interactions with the surfactant tail.
In the case of C
12
EO
8
, IBU presents a terminal
carboxyl group that may interact by hydrogen bonds with the
PEO head groups. These interactions could drive the drug
to the outer portion of the micellar core, in a way that the
carboxyl group sticks to the palisade layer interacting with
the PEO head groups, while the hydrophobic portion of the
molecule stays preferentially in contact with the hydrophobic
core (Rosen, 1989; Torchilin, 2001). Therefore, being
located mainly in the outer portion of the micelle core, we
could expect IBU to lower the CMC of C
12
EO
8
.
FIGURE 4 – Surface tension (γ) as a function of log n-
dodecyl octa(ethylene oxide) (C
12
EO
8
) concentration plots
at 25 oC in A-pure water, B-phosphate buffer pH 7.4, and
C- ibuprofen-saturated (4 mM) phosphate buffer pH 7.4.
TABLE I – Critical Micelle Concentrations (CMC) experimentally determined for the surfactants SDS, DTAB and
C
12
EO
8
* in water, phosphate buffer pH 7.4, and ibuprofen-saturated (4 mM) phosphate buffer pH 7.4
Surfactant Critical Micelle Concentration – CMC
H
2
O Buffer Buffer + IBU
SDS 8.7 mM 4.7 mM 4.7 mM
DTAB 15.9 mM 13.5 mM 11.0 mM
C
12
EO
8
81 µM 85 µM 47 µM
* SDS corresponds to sodium dodecyl sulphate, DTAB to dodecyltrimethylammonium bromide and C
12
EO
8
 to n-dodecyl
octa(ethylene oxide).
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Finally, with DTAB, the electrostatic interactions
between the negatively charged IBU and the positively
charged DTAB must have caused a decrease in the
repulsive forces between the head groups of the surfactant
molecules, contributing to the micellization process and
thus decreasing the CMC  value. Since IBU is an
amphiphilic drug, we can view the DTAB/IBU system as
a binary surfactant mixture. According to Puvvada and
Blankschtein (1992), in aqueous solutions of binary
surfactant mixtures synergistic interactions between the
two surfactant species result in CMC values that can be
substantially lower than those in solutions containing the
constituent single surfactants.
Figures 5, 6, and 7 present the results of IBU solubility
as a function of the surfactants SDS, DTAB, and C
12
EO
8
concentrations, respectively. Irrespective of the surfactant
type, the solubility of IBU increased linearly with increasing
surfactant concentration, as a consequence of the
association between the drug and the micelles. As can be
seen from the solubilization curves for IBU in SDS and
DTAB, the increase in drug solubility is observed only for
surfactant concentrations above the CMC (4.7 mM for SDS
and 11 mM for DTAB), clearly demonstrating that micellar
solubilization is taking place. This relationship cannot be
visualized from the solubilization curve of the drug in C
12
EO
8
because of the very low CMC of this nonionic surfactant
(47 μM). However, measurements at surfactant
concentrations below the CMC (data not presented) have
shown no increase in IBU solubility, confirming the
correlation between increasing solubility and micellization
also for the nonionic surfactant. It is important to point out
that the linear relations obtained for IBU refer only to
surfactant concentrations above the CMC. The 80 mM
DTAB and the 80 mM C
12
EO
8
 micellar solutions resulted
in a 16-fold increase in solubility of IBU when compared to
the buffer solution, whereas the 80 mM SDS micellar
solution resulted in a 5.5-fold increase in IBU solubility.
The influence of the anionic surfactant SDS on the
solubilization of IBU was smaller than that of the other
surfactants studied, as shown in Figure 5. IBU is an acid
drug that is found to be 99.7% dissociated in pH 7.4. As a
consequence, the repulsion between the drug and the SDS
head group may be expected to limit solubilization. Mall et
al. (1996) observed similar effect for sulfanilamide and
SDS, evidenced by a positive free energy of adhesion and
positive enthalpy of transfer. According to these authors,
the interaction between the head group of SDS and the
drug has a dominant influence on solubilization.
Nevertheless, it is important to take into account that the
pK
a
 of IBU must shift to a higher value in the presence of
SDS micelles. Therefore, the ionized fraction of SDS is
probably smaller than the predicted in pure water. One
possibility of lowering the repulsion between SDS micelles
and IBU would be switching the pH to lower values, in
order to favor the molecular form of the drug.
One should keep in mind that the extent of
solubilization of IBU in SDS micelles could increase when
working at higher ionic strength values. In this case, there
would be a screening of the charges in the SDS micelles
and consequently lowering the electrostatic repulsion
between the negatively-charged micelles and IBU. The
screening of the charges would also lead to micellar
growth, resulting in increased volume in the inner core of
FIGURE 5 – Solubility curve of ibuprofen (IBU) as a
function of sodium dodecyl sulphate (SDS) concentration
in phosphate buffer 5 mM, pH 7.4 at 25 oC. The error bars
represent 95% confidence limit for the measurements.
FIGURE 6 – Solubility curve of ibuprofen (IBU) as a
function of dodecyltrimethylammonium bromide (DTAB)
concentration in phosphate buffer 5 mM, pH 7.4 at 25 oC.
The error bars represent 95% confidence limit for the
measurements.
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the micelle, where the IBU would be located. For DTAB
micellar solutions, which are positively charged, the
opposite effect would be observed.
On the other hand, the enhanced solubility of IBU in
DTAB micellar solutions (Figure 6), is a consequence of
the electrostatic interactions between the positively
charged surfactant molecules and the negatively charged
drug, resulting in mixed IBU/DTAB micelles and
depressing the CMC, as discussed earlier. In fact, Caeta-
no et al. (2002) had already observed this phenomenon of
comicellization for the negatively charged surfactant SDS
and trifluoperazine (TFP), an amphiphilic cationic drug
used as antipsychotic and tranquilizer. The authors
demonstrated based on SAXS (Small Angle X-ray
Scattering) studies that the micellar ionization coefficient
decreases upon TFP incorporation, until the intermicellar
electrostatic interaction completely disappears over the
scattering curves. Moreover, the electrostatic interaction
between the positively charged drug and the negatively
charged SDS must cause a decrease in the repulsive for-
ces between the head groups of the surfactant. This effect
lowered the cmc and resulted in spherical-to-cylindrical
micelle shape transformation. We believe that the same
kind of behavior should take place for DTAB and IBU.
Similar solubility profiles were observed for IBU in
DTAB and C
12
EO
8
 micellar solutions. Unlike ionic
surfactants, with relative small polar head groups, micelles
formed by PEO nonionic surfactants have an alternative
locus for solubilization. Although there is space for
hydrating water in the outer parts of these micelles, there
is virtually none close to the hydrocarbon core due to the
crowding of the polyoxyethylene chains (Barry, El Eini,
1976). As a result, a region that is largely purely
polyoxyethylene rather than polyoxyethylene-water is
formed, and may work as a site of solubilization of semi-
polar compounds, such as ionized IBU. In this particular
case, hydrogen bonds might be taking place between IBU
and the polyoxyethylene head groups.
The increased solubility of the drug in C
12
EO
8
micellar solutions is not only a consequence of micelle-drug
interaction, but also of the fraction of surfactant in the
micellar form. For the nonionic surfactant C
12
EO
8
, at the
same concentration of the ionic surfactants, the molar
fraction of surfactant in the micellar form is higher, since
the CMC is much lower. In order to make this statement
clear, the molar solubilization capacities of the surfactants,
as well as the partition coefficients, were calculated and
are presented in Table II. According to the values obtained,
the molar solubilization capacity of DTAB, χ = 0.97, is
higher than the molar solubilization capacity of C
12
EO
8
, χ
= 0.72, as a consequence of the electrostatic interactions.
However, because of the stronger tendency of the nonionic
surfactant in forming micelles in solution, at the same
surfactant concentration, we obtained the same solubility
of IBU both in DTAB and C
12
EO
8
. This can also be seen
based on the molar micelle-water partition coefficients,
K
M
DTAB = 243 and K
M
C12E8 =180. Accordingly, the tendency
of IBU to partition preferentially with the DTAB micelle
is higher than the tendency to partition with the C
12
EO
8
micelle.
The anionic surfactant SDS presented the lowest
values of χ and K
M
. As discussed earlier, IBU bears a
negative charge and consequently repulsive interactions
are present between the drug and the negatively charged
head groups of SDS, reducing the possible loci of
solubilization of this drug in SDS micelles.
Knowledge of the thermodynamic parameters
controlling solubilization is helpful to a better understanding
of the mechanisms involved in this process. From the
thermodynamic point of view, the solubilization can be
considered as a normal partitioning of the drug between
two phases, micelle and aqueous, and the standard free
energy of solubilization, ΔG
S
0 (J mol-1), can be represented
by the following expression (Torchilin, 2001):
(4)
where R is the universal constant of the gases, T is the
absolute temperature, and K
M
 is the molar partition
coefficient between the micelle and the aqueous phase.
The ΔG
S
0 value was calculated for all systems, and the
results are presented in Table II. For all systems studied
FIGURE 7 – Solubility curve of ibuprofen (IBU) as a
function of n-dodecyl octa(ethylene oxide) (C
12
EO
8
)
concentration in phosphate buffer 5 mM, pH 7.4 at 25 oC.
The error bars represent 95% confidence limit for the
measurements.
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ΔG
S
0 was negative, indicating spontaneous solubilization.
The lowest value was observed for DTAB micellar system,
confirming that the solubilization process of negatively
charged drugs is energetically more favorable in cationic
micellar systems, due to electrostatic interactions. On the
contrary, the highest ΔG
S
0 value corresponded to the SDS
micellar system.
4. CONCLUSION
In this work, the influence of the surfactant head
group on the extent of ibuprofen solubilization was
investigated. The anionic surfactant SDS presented the
worst solubilization profile for IBU as a result of
electrostatic repulsions between the drug and the
surfactant head group, whereas the cationic surfactant
DTAB provided the highest molar solubilization capacity of
IBU due to the electrostatic attractions. Similar solubility
profiles were observed for IBU in DTAB and C
12
EO
8
micellar solutions. The increased solubility of the drug in
C
12
EO
8
 micellar solutions was a consequence of IBU
interaction with the PEO surfactant head group and also
of the molar fraction of surfactant in the micellar form that
is higher for nonionic surfactants due to the low CMC.
 Therefore, nonionic surfactants could be considered
the best alternative for solubilization of IBU, as well as of
other acid drugs. This class of surfactants provides a
reasonable molar solubilization capacity combined with low
CMC value, resulting in increased solubility of IBU.
Moreover, the low toxicity of nonionic surfactants makes
them particularly interesting for solubilization and drug
delivery purposes. The possibility of combining nonionic
surfactants with small amounts of cationic surfactants
(considering the toxicity of this class of surfactants),
resulting in mixed micellar systems, should also be
investigated for solubilization of negatively charged drugs.
In addition, Small Angle X-ray Scattering (SAXS) studies
on the interaction of IBU with micelles of SDS, DTAB and
C
12
EO
8
 are in progress, aiming at a deeper understanding
about the nature of these interactions as well as the
properties of the aggregates obtained.
RESUMO
Solubilização micelar do ibuprofeno – influência do
grupo polar dos tensoativos no grau de
solubilização
Uma propriedade importante das micelas, do ponto de
vista farmacêutico, refere-se ao potencial destas em
solubilizar fármacos pouco solúveis em água, aumen-
tando sua biodisponibilidade. No presente trabalho,
estudou-se a solubilização de ibuprofeno (IBU) em
soluções micelares constituídas de três tensoativos
apresentando a mesma cauda apolar, porém diferen-
tes grupos hidrofílicos. Os tensoativos estudados fo-
ram dodecil sulfato de sódio (SDS), brometo de
dodeciltrimetilamônio (DTAB) e óxido de n-dodecil
octaetileno (C
12
EO
8
). De acordo com os resultados
obtidos, a solubilidade do IBU aumentou linearmente
com o aumento da concentração de todos os
tensoativos estudados, devido às interações entre as
micelas e o fármaco. O fármaco IBU apresentou um
aumento de 16 vezes em sua solubilidade na presença
de DTAB 80 mM e de C
12
EO
8
 80 mM. Por outro lado,
na presença de SDS 80 mM a solubilidade do IBU au-
mentou apenas 5,5 vezes. O maior valor para o
parâmetro capacidade molar de solubilização (χ) foi
observado com o tensoativo DTAB, χ = 0,97, seguido
pelo C
12
EO
8
, χ = 0,72 e, finalmente, o SDS, χ = 0,23.
Entretanto, devido à grande tendência do C
12
EO
8
 em
formar micelas, o perfil de solubilidade do IBU foi se-
melhante em DTAB e C
12
EO
8
.
Unitermos: Solubilização micelar. Cabeça polar.
Ibuprofeno. Tensoativo.
TABLE II - Solubilization parameters molar solubilization capacity (χ) and molar micelle-water partition coefficient (K
M
),
and thermodynamic parameter free energy of solubilization (ΔG
S
0) for the solubilization of ibuprofen in SDS, DTAB and
C
12
EO
8
Micellar System Solubilization and thermodynamic parameters
χ KM ΔGS0 (kJ mol-1)
SDS 0.23 58 - 10.06
DTAB 0.97 243 - 13.61
C
12
EO
8
0.72 180 - 12.87
SDS corresponds to sodium dodecyl sulphate, DTAB to dodecyltrimethylammonium bromide and C
12
EO
8
 to n-dodecyl
octa(ethylene oxide). *surfactant solutions, at 25 oC, in phosphate buffer pH 7.4. The error in the calculated parameters
was 5%.
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